London N, Thomson C J, Amyes S G, Stobberingh E
University of Limburg, Department of Medical Microbiology, Maastricht, The Netherlands.
FEMS Immunol Med Microbiol. 1995 Apr;11(2):107-11. doi: 10.1111/j.1574-695X.1995.tb00096.x.
As part of a surveillance programme of the prevalence of antibiotic resistance, the faecal bacteria of healthy people (n = 1348) were examined, and the antibiotic resistance of the Escherichia coli strains determined. One strain out of 142 amoxycillin-resistant isolates, E. coli strain 1662, was also resistant to piperacillin-tazobactam but susceptible to amoxycillin-clavulanic acid. The piperacillin-tazobactam resistance determinant was transferable to standard E. coli strains by conjugation. However, the strain produced a beta-lactamase with several characteristics very similar to those of the TEM-1 beta-lactamase, i.e. pI of 5.4, an M(r) value of 22,000 and a comparable substrate profile. The enzyme was as efficiently inhibited by clavulanic acid and tazobactam as the TEM-1 and TEM-2 beta-lactamases but more than the amoxycillin-clavulanic acid-resistant TRC-1 enzyme. The transferable resistance to piperacillin-tazobactam appears to be mediated by a novel resistance mechanism that has previously not been described.
作为抗生素耐药性流行监测计划的一部分,对健康人群(n = 1348)的粪便细菌进行了检测,并测定了大肠杆菌菌株的抗生素耐药性。在142株阿莫西林耐药分离株中,有一株大肠杆菌菌株1662,对哌拉西林 - 他唑巴坦也耐药,但对阿莫西林 - 克拉维酸敏感。哌拉西林 - 他唑巴坦耐药决定簇可通过接合转移至标准大肠杆菌菌株。然而,该菌株产生的一种β-内酰胺酶具有几个与TEM-1β-内酰胺酶非常相似的特征,即pI为5.4,M(r)值为22,000,底物谱相当。该酶被克拉维酸和他唑巴坦抑制的效率与TEM-1和TEM-2β-内酰胺酶相同,但比耐阿莫西林 - 克拉维酸的TRC-1酶更有效。对哌拉西林 - 他唑巴坦的可转移耐药性似乎是由一种以前未描述过的新耐药机制介导的。